BPC-157 Research Overview: Body Protection Compound Science 2026

What is BPC-157?

BPC-157 (Body Protection Compound) is a synthetic 15-amino-acid pentadecapeptide derived from a protein fragment found in human gastric juice. With sequence GEPPPGKPADDAGLV and a molecular weight of 1419.5 Da, the compound is notable for exceptional stability in biological conditions — it withstands acidic gastric pH and resists many proteolytic enzymes that rapidly degrade other research peptides. This stability profile makes BPC-157 a tractable research tool for in vitro and in vivo regenerative biology and cytoprotection studies. Researchers can access BPC-157 research peptide at Advanced Peptide Science at 99%+ HPLC-verified purity.

Research Background

BPC-157 was isolated from research into the cytoprotective properties of human gastric juice protein fragments. The natural occurrence in gastric juice suggested a role in mucosal defence and tissue protection — a research hypothesis subsequently extended to systemic cytoprotection across many tissue types. The compound has become a foundational research tool in the regenerative biology category and is frequently paired with TB-500 for combined cytoprotection + actin-regulatory mechanism studies.

Mechanism of Action

BPC-157 mechanism research focuses on three principal pathways. First, activation of early growth response 1 (EGR-1) transcription factor, with downstream effects on fibroblast activation, collagen synthesis, and tissue-repair gene programmes. Second, upregulation of vascular endothelial growth factor receptor 2 (VEGFR2) with consequent angiogenic signalling — increased microvessel formation supports tissue-repair processes. Third, modulation of the nitric oxide synthase (NOS) pathway with implications for vasodilation, blood flow regulation, and downstream NO-dependent signalling cascades. Additional research focuses on fibroblast migration, tendon-to-bone healing in preclinical orthopaedic models, and gastrointestinal barrier integrity investigation that reflects the compound’s natural gastric-juice origin.

Key Research Findings

EGR-1 Transcription Factor Activation

EGR-1 is a zinc-finger transcription factor activated rapidly in response to tissue injury and growth signals. BPC-157 research investigates upregulation of EGR-1 expression and downstream transcriptional activation of tissue-repair gene programmes. EGR-1 target genes include collagen synthesis genes, growth factor receptors, and angiogenic signalling components — making EGR-1 activation a central mechanistic hypothesis for BPC-157’s regenerative effects.

VEGFR2 and Angiogenesis

VEGFR2 (vascular endothelial growth factor receptor 2) is the principal angiogenic receptor on endothelial cells. BPC-157 research investigates upregulation of VEGFR2 expression with consequent enhanced angiogenic responsiveness — supporting microvessel formation and tissue revascularisation in preclinical wound healing and ischaemia models.

Gastrointestinal Barrier Integrity

The compound’s gastric-juice origin makes investigation of GI barrier integrity a logical research application. Studies investigate BPC-157 effects on tight junction protein expression, mucosal barrier function, and intestinal epithelial integrity in preclinical IBD and gut barrier disruption models.

Research Applications and Comparison

BPC-157 occupies a foundational position in the Tissue Repair & Regenerative category. The compound is widely paired with TB-500 (Thymosin Beta-4 fragment) for combined cytoprotection + actin-regulatory research, with GHK-Cu for combined cytoprotection + copper-dependent remodelling research, and with KPV for combined cytoprotection + anti-inflammatory research. Pre-formulated research blends including the BPC-157 + TB-500 Blend, Glow Blend, and KLOW Blend simplify multi-compound research protocols.

Research Specifications

Molecular Weight	1419.5 Da
Sequence	GEPPPGKPADDAGLV (15-amino-acid pentadecapeptide)
Origin	Synthetic, derived from human gastric juice protein fragment
Stability	Highly stable in acidic and proteolytic conditions
Format	Lyophilized powder in sterile vial
Purity	≥ 99% (HPLC verified)
Storage	-20 °C, protect from light

Frequently Asked Questions

What does the BPC in BPC-157 stand for?

BPC stands for Body Protection Compound, reflecting the compound’s cytoprotective activity in preclinical research models. The “157” designation refers to a research-development identifier rather than a structural feature.

What is the BPC-157 sequence?

BPC-157 is a 15-amino-acid pentadecapeptide with sequence GEPPPGKPADDAGLV (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) and a molecular weight of 1419.5 Da.

Where can researchers source BPC-157?

BPC-157 research peptide is available at Advanced Peptide Science at 99%+ HPLC-verified purity with batch-specific Certificate of Analysis documentation available on request.

Is BPC-157 approved for human use?

Advanced Peptide Science supplies BPC-157 exclusively for in vitro and in vivo scientific research. Not for human consumption. Research use only.

---

For Research Use Only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.